Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Connect Biopharma Limite...

    NASDAQ: CNTB · Real-Time Price · USD
    1.80
    -0.12 (-6.25%)
    At close: Aug 19, 2025, 3:59 PM
    1.81
    0.56%
    After-hours: Aug 19, 2025, 04:04 PM EDT

    Connect Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 48K 1.91M 24.12M n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 183.53K n/a 481.87K 506.13K 527.3K 503.34K 412.05K 221.39K
    Gross Profit
    		 48K 1.73M 23.64M -481.87K -506.13K -527.3K -503.34K -412.05K -221.39K
    Operating Income
    		 -13.42M -24.91M 7.31M -27.23M -34.84M -54.28M -63.38M -58.26M -41.09M
    Interest Income
    		 619K 4.03M 822K -2.49M 2.49M 1.29M 271.1K 54.89 22.92
    Pretax Income
    		 -12.84M -23.05M 7.71M -28.87M -30.52M -56.49M -59.63M -56.39M -145.71M
    Net Income
    		 -12.9M -23.22M 7.65M -28.92M -30.58M -56.68M -59.74M -56.65M -145.71M
    Selling & General & Admin
    		 4.7M 11.8M 7.43M 5.92M 7.61M 9.16M 11.21M 11.17M 7.19M
    Research & Development
    		 8.77M 15.9M 13.32M 25.18M 26.73M 44.6M 50.66M 46.68M 33.67M
    Other Expenses
    		 n/a -1.07M -3.94M -4.35M n/a n/a -940.31K n/a n/a
    Operating Expenses
    		 13.47M 26.63M 16.81M 27.74M 34.34M 53.76M 60.93M 57.85M 40.87M
    Interest Expense
    		 n/a -20K 20K -10.39K 10.39K 12.32K 8.72K n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a 5.94M 7.58M 9.12M -9.12M 11.16M 7.19M
    Cost & Expenses
    		 13.47M 26.82M 16.81M 27.23M 34.84M 54.28M 60.4M 58.26M 41.09M
    Income Tax Expense
    		 55K 162.58K 60K 55.22K 64.78K 186.17K 111.34K 263.87K n/a
    Shares Outstanding (Basic)
    		 55.5M 55.19M 55.14M 55.07M 55.05M 55.02M 55.02M 53.74M 46.94M
    Shares Outstanding (Diluted)
    		 55.5M 55.19M 55.55M 55.07M 55.05M 55.02M 55.02M 53.74M 46.94M
    EPS (Basic)
    		 -0.23 -0.42 0.14 -0.52 -0.56 -1.03 -13.47 -1.05 -3.1
    EPS (Diluted)
    		 -0.23 -0.42 0.14 -0.52 -0.56 -1.03 -13.47 -1.05 -3.1
    EBITDA
    		 -13.25M -22.87M 8.2M -28.37M -30M -53.76M -57.55M -57.85M -40.87M
    EBIT
    		 -13.42M -23.05M 7.72M -28.85M -30.51M -56.48M -61.56M -56.39M -20.58M
    Depreciation & Amortization
    		 171K 183.53K 476K 481.87K 506.13K 527.3K 486.34K 412.05K 221.39K

    Add to Watchlist